Show simple item record

dc.contributor.authorHuerga, H*
dc.contributor.authorFerlazzo, G*
dc.contributor.authorWanjala, S*
dc.contributor.authorBastard, M*
dc.contributor.authorBevilacqua, P*
dc.contributor.authorArdizzoni, E*
dc.contributor.authorSitienei, J*
dc.contributor.authorBonnet, M*
dc.date.accessioned2019-02-26T17:15:28Z
dc.date.available2019-02-26T17:15:28Z
dc.date.issued2019-02-11
dc.date.submitted2019-02-19
dc.identifier.citationMortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis. 2019, 19 (1):132 BMC Infect. Dis.en
dc.identifier.issn1471-2334
dc.identifier.pmid30744603
dc.identifier.doi10.1186/s12879-019-3775-z
dc.identifier.urihttp://hdl.handle.net/10144/619341
dc.description.abstractEmpirical treatment of tuberculosis (TB) may be necessary in patients with negative or no Xpert MTB/RIF results. In a context with access to Xpert, we assessed mortality in the 6 months after the initial TB consultation among HIV-positive and HIV-negative patients who received empirical TB treatment or TB treatment based on bacteriological confirmation and we compared it with the mortality among those who did not receive TB treatment.en
dc.language.isoenen
dc.publisherBioMed Centralen
dc.rightsArchived with thanks to BMC Infectious Diseasesen
dc.titleMortality in the first six months among HIV-positive and HIV-negative patients empirically treated for tuberculosis.en
dc.identifier.journalBMC infectious diseasesen
refterms.dateFOA2019-02-26T17:15:28Z


Files in this item

Thumbnail
Name:
Huerga et al - 2019 - Mortality ...
Size:
1.583Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record